Reframing an Autophagy Study for Scopus Q1 Peer Review

The consultation distinguished observation, association and mechanism. The paper was reframed to test whether autophagic activity was associated with the resistant phenotype and whether pathway modulation changed drug response, matching claims to the experiments actually completed.

Untreated, vehicle and appropriate positive or negative controls were added across matched experimental conditions, and static marker interpretation was replaced with a design capable of distinguishing increased formation from impaired degradation.

Pharmacological modulation was combined with an independent genetic approach to reduce reliance on one inhibitor, and molecular changes were linked with drug sensitivity, apoptosis and recovery rather than protein expression alone.

Biological replicates, normalisation, loading controls, image acquisition and statistical comparisons were clarified. Results were reorganised as a sequence of questions, each stating its experimental purpose, control comparison and evidence boundary.

Journals were screened for molecular and cell biology scope, mechanistic expectations, cancer-cell relevance, article type and publication cost, with Scopus coverage and quartile verified at the time of selection. The chosen target expected multiple lines of evidence and complete figure documentation.

A flux experiment and genetic knockdown condition were added to address pathway-specificity concerns, quantification and uncropped source images were organised for review, language implying clinical effectiveness was removed, and the revision letter distinguished completed experiments, revised interpretations and justified limitations.